[1] 肾脏病医疗质控中心.血液净化标准操作规程(2021)[S].国家卫生健康委办公厅,2021:203. [2] LOCATELLI F, ALTIERI P, ANDRULLI S, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD [J]. J Am Soc Nephrol, 2010, 21(10):1798-1807. [3] 中国医药教育协会肾病与血液净化专业委员会血液透析低血压防治专家组.血液透析中低血压防治专家共识(2022)[J].中华内科杂志,2022,61(3):269-281. [4] GUL A, MISKULIN D, HARFORD A, et al. Intradialytic hypotension[J]. Curr Opin Nephrol Hypertens, 2016, 25(6):545-550. [5] FLYTHE J E, CHANG T I, GALLAGHER M P, et al. Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int, 2020, 97(5):861-876. [6] 曹虎男,刘玉秀,樊蕊,等.老年维持性血液透析患者透析中低血压的危险因素分析[J]. 中华肾脏病杂志,2023,39(2):101-111. [7] 张晓玲,白久旭,郝峻烽,等.老年维持性血液透析患者血管钙化与透析间低血压的相关性研究[J].中华保健医学杂志,2017,19(6): 492-495. [8] LOK C E, HUBER T S, LEE T, et al.KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update[J]. Am J Kidney Dis, 2020, 75(4):S1-S164. [9] 费世枝,熊飞,李红兵,等. 2018年度武汉地区老年维持性血液透析患者血管通路调查分析[J].临床肾脏病杂志,2020,20(7):551-556. [10] 黄玉萍,徐辉,王道洋,等. 蚌埠地区老年维持性血液透析患者血管通路调查分析[J].中国血液净化,2021,20(12):835-838. [11] 傅华珍,丁小容,陈丹,等.基于随机森林算法的糖尿病肾病患者血液透析中发生低血压预测模型的建立[J].中国中西医结合肾病杂志,2023,24(6):493-496. [12] SABRY A A, ELSHAFEY E M, ALSARAN K, et al. The level of C-reactive protein in chronic hemodialysis patients:a comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers[J]. Hemodial Int, 2014, 18(3):674-679. [13] SACHDEVA M,HUNG A,KOVALCHUK O,et al. The initial vascular access type contributes to inflammation in incident hemodialysis patients[J]. Int J Nephrol, 2012,2012:917465. [14] 焦占峰,张宜明,马小芬,等.不同超滤率对糖尿病肾病患者维持性血液透析中低血压及心血管死亡发生率影响[J]. 临床军医杂志,2021,49(9):1002-1004. [15] 王质刚. 血液净化学[M]. 2版,北京:北京科学技术出版社, 2003:171. |